Hedge fund urges board shake-up at Novavax over struggling Covid vaccine

Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news